FNCE 2022

October 10, 2022, 1:30 - 3:00pm ET

Join IAFNS, the Academy of Nutrition and Dietetics Research Dietetic Practice Group (RDPG), and the American Society for Nutrition Microbiology Research Interest Section (RIS) for this session at the annual meeting of nutrition professionals.

Achieving health goals is dependent upon the provision of evidence-based dietary recommendations. As the popularity of direct-to-consumer gut microbiome tests expands, it is important to understand the predictive value of these tests and promise for improving health of the users. Speakers in this session will provide a review of the state-of-the-science related to gut microbiome research, its promise for producing individualized dietary recommendations, and outline what yet needs to be known. By sharing researcher, clinical, and nutrition practitioner perspectives, this session will bring clarity to the current translatability of gut microbiome science and value of direct-to-consumer gut microbiome tests for supporting health, as well as the future promise of gut microbiome science and related consumer-directed tools.

Panel:

• Philip Karl, PhD, RD, US Army Research Institute of Environmental Medicine – Moderator
• Levi Tiegen, PhD, RD, University of Minnesota Medical School
• Diane E. Hoffman, JD, MS, University of Maryland, Baltimore
• Purna C. Kashyap, MBBS, Mayo Clinic

Performance Indicators:

• 6.2.3 Interprets data to make recommendations and to inform decisions
• 10.2 Implements the nutrition care process to ensure individual health goals are established
• 8.1.2 Applies knowledge of food and nutrition as well as the biological, physical and social sciences in practice

This session is supported by the IAFNS Gut Microbiome Committee.

October 11, 2022, 8:30 - 9:30 am ET

Years of discussion among the dietetics community paired with a plethora of data from peer-reviewed human studies have culminated in the first ever dietary recommendation for a bioactive compound. In this session, members of the Academy-appointed Expert Panel will present the guideline recommendation for flavan-3-ols and cardiometabolic health, including an overview of the flavan-3-ols (a type of flavonoid), the supporting evidence for improved cardiometabolic health, and the importance of a food-based approach to intake. Translating this into practice requires a discussion of not only health equity but also barriers and facilitators to guideline adoption. As such, this session will highlight key considerations and strategies for successful implementation. Attendees will leave with an understanding of how they can implement this guideline to optimize cardiometabolic health and conduct future studies to fill critical research gaps.

Panel:

Kristi Crowe-White, PhD, RDN, The University of Alabama - Moderator
Kim Stote, PhD, MPH, RDN, State University of New York, Empire State College
Taylor Wallace, PhD, CFS, FACN, Think Healthy Group / George Mason University

Performance Indicators:

• 8.1.2 Integrates knowledge of biological, physical, and social sciences with knowledge of food and nutrition to make decisions related
  to nutrition care
• 8.2.4 Integrates new knowledge of disease states and clinical conditions into practice.
• 6.2.3 Analyzes and interprets data to form valid conclusions and to make recommendations.

This session is supported by the IAFNS Bioactives Committee.